| Wartość aktywów (mln USD): | 3 |
| Liczba spółek: | 20 |
| Stopa dywidendy: | - % |
| Opłata za zarządzanie:: | 0.59 % |
| Klasa aktywów: | Equity |
ISIN: US0321085328
Wystawca ETF: Amplify| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y |
|---|
| Sektor | Udział % |
|---|
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | 452 491 | 16.3 | 427 |
| Novo Nordisk A/S | NVO | 283 446 | 10.2 | 5 951 |
| Regeneron Pharmaceuticals Inc | REGN | 229 037 | 8.2 | 303 |
| Amgen Inc | AMGN | 205 899 | 7.4 | 610 |
| Chugai Pharmaceutical Co Ltd | 4519.T | 203 113 | 7.3 | 3 800 |
| Roche Holding AG | ROG.SW | 149 477 | 5.4 | 383 |
| Merck & Co Inc | MRK | 148 399 | 5.3 | 1 518 |
| AstraZeneca PLC | AZN | 145 054 | 5.2 | 1 594 |
| AbbVie Inc | ABBV | 138 696 | 5.0 | 587 |
| Pfizer Inc | PFE | 130 208 | 4.7 | 5 200 |
| Shionogi & Co Ltd | 4507.T | 122 312 | 4.4 | 7 100 |
| Innovent Biologics Inc | 1801.HK | 117 669 | 4.2 | 10 500 |
| CSPC Pharmaceutical Group Ltd | 1093.HK | 94 790 | 3.4 | 100 000 |
| Zealand Pharma A/S | ZEAL.CO | 90 798 | 3.3 | 1 130 |
| Hims & Hers Health Inc | HIMS | 86 670 | 3.1 | 2 497 |
| Scholar Rock Holding Corp | SRRK | 52 956 | 1.9 | 1 317 |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 1276.HK | 37 271 | 1.3 | 4 400 |
| Hanmi Pharm Co Ltd | 128940.KS | 33 209 | 1.2 | 110 |
| United Laboratories International Holdings Ltd/The | 3933.HK | 27 142 | 1.0 | 18 000 |
| Invesco Government & Agency Portfolio 12/31/2031 | AGPXX | 21 587 | 0.8 | 21 587 |
| Cash & Other | Cash&Other | 6 707 | 0.2 | 6 707 |